Jonathan E. Lim - 31 Dec 2022 Form 5 Insider Report for Erasca, Inc. (ERAS)

Key filing fact

Jonathan E. Lim filed Form 5 for Erasca, Inc. (ERAS) on 15 Feb 2023.

Key facts

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Official SEC Source

Ownership activity is grounded in SEC Form 5 disclosures.

ERAS transaction

Gift

Transaction value: $0
Shares: -2,000,006
Change %: -9.9%
Price: $0.000000
Shares after: 18,196,216
Date: 30 Nov 2022
Ownership: Jonathan E. Lim and Conyee T. Lim Family Trust, dated April 28, 2005
Footnotes: F1, F2

ERAS holding

No transaction description listed

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	Transfer of shares to a trust of which the children of the Reporting Person and his spouse are beneficiaries.
F2	The securities reported herein may be deemed beneficially owned by each of (i) Jonathan E. Lim, M.D. and (ii) Conyee T. Lim, M.D., who are co-trustees of the Jonathan E. Lim and Conyee T. Lim Family Trust, dated April 28, 2005.
F3	Consists of shares held directly by City Hill, LLC ("City Hill"). Jonathan E. Lim, M.D. serves as the managing partner of City Hill. Dr. Lim exercises voting and dispositive control over the securities held by City Hill and is therefore deemed to be a beneficial owner of securities owned by City Hill. Dr. Lim disclaims beneficial ownership of the reported securities held by City Hill, except to the extent of his pecuniary interest therein.